<DOC>
	<DOC>NCT00092729</DOC>
	<brief_summary>The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).</brief_summary>
	<brief_title>An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>Women 18 years of age or older suffering from painful menstruation Women taking medications that are not allowed in the study (such as pain medications, antidepressants, tranquilizers, hypnotics, sedatives, or oral contraceptives). Women who are pregnant, breastfeeding or within 6 weeks of giving birth</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>